![]() Bio-Techne Bio-Techne is a company that provides researchers in life science and clinical diagnostics with reagent instruments, custom manufacturing, and testing services. | ![]() Humanigen Humanigen is repositioning and developing its proprietary monoclonal antibodies to meet some critical unmet needs in cancer science. | ||
Founding Date | Founding Date 1981 | Founding Date 2000 | Founding Date 1842 |
Type | Type Public | Type Public | Type Subsidiary |
Tags | |||
Locations | Locations Minneapolis, US HQ Toronto, CA Praha, CZ Copenhagen, DK Noyal Châtillon Sur Seiche, FR Noyal Châtillon Sur Seiche, FR Planegg, DE see more | Locations Burlingame, US HQ Dublin, IE London, GB Kansas City, US | Locations Guildford, GB HQ São José Dos Campos, BR Sofia, BG Milton, CA Pointe Claire, CA Vaughan, CA Beijing, CN see more |
Employees | Employees 3,0502% increase | Employees 233% decrease | Employees 9465% increase |
Valuation ($) | Valuation ($) 11.2 b | Valuation ($) 4.3 m | Valuation ($) N/A |
Financial | |||
Revenue (est.) | Revenue (est.) $1.2b (FY, 2025) | Revenue (est.) $2.5m (FY, 2022) | Revenue (est.) £165.1m (FY, 2025) |
Cost of goods | Cost of goods $429.4m (FY, 2025) | Cost of goods N/A | Cost of goods £111m (FY, 2025) |
Gross profit | Gross profit $790.3m (FY, 2025) | Gross profit N/A | Gross profit £54.1m (FY, 2025) |
Net income | Net income $73.4m (FY, 2025) | Net income ($70.7m) (FY, 2022) | Net income £13.9m (FY, 2025) |
Operating ⚠ | |||
Patent Applications | Patent Applications 270 (FY, 2022) | Patent Applications 17 (FY, 2017) | Patent Applications N/A |

Humanigen is repositioning and developing its proprietary monoclonal antibodies to meet some critical unmet needs in cancer science.
View company